跳至主要内容
临床试验/NCT01435967
NCT01435967已完成不适用

Observational, Ecological, Database Study on Epidemiology of Hospitalisations With Rotavirus Gastroenteritis Confirmed in Children Aged ≤5 Years, and Any Impact in the Change From Lyophilised to Liquid Formulation of Rotarix™, in Belgium

GlaxoSmithKline1 个研究点 分布在 1 个国家目标入组 1 人开始时间: 2011年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1
试验地点
1
主要终点
Occurrence of rotavirus in hospitalised children aged ≤5 years during pre-introduction, introduction and post-introduction period of liquid formulation Rotarix™

研究概览

简要总结

The aim of this study is to monitor any impact in the change from the lyophilised formulation to the liquid formulation of the Rotarix™ vaccine on hospitalisations for rotavirus gastroenteritis. This is planned to be assessed by comparing trends of hospitalisations due to laboratory confirmed rotavirus gastroenteritis in children <=5 years of age, before and after introduction of the liquid formulation of the vaccine in Belgium.

研究设计

研究类型
Observational
观察模型
Ecologic Or Community
时间视角
Retrospective

入排标准

年龄范围
— 至 5 Years(Child)
性别
All
接受健康志愿者

入选标准

  • All subjects must satisfy ALL the following criteria at study entry:
  • Child aged ≤5 years with opportunity to receive lyophilised or liquid formulation of Rotarix™;
  • Hospitalised at one of the participating centres in Belgium;
  • A stool sample has been provided for a rotavirus detection test during the study period;
  • Laboratory test result of rotavirus is available.

排除标准

  • 未提供

结局指标

主要结局

Occurrence of rotavirus in hospitalised children aged ≤5 years during pre-introduction, introduction and post-introduction period of liquid formulation Rotarix™

时间窗: up to 2 years post-introduction of liquid formulation of Rotarix™.

次要结局

  • Occurrence of rotavirus detected by laboratory tests in children of various age, gender and location (centre and region).(up to 2 years post-introduction of liquid formulation of Rotarix™.)
  • Occurrence of rotavirus detected by laboratory tests at a specific time (month and year).(up to 2 years post-introduction of liquid formulation of Rotarix™.)
  • Occurrence of rotavirus detected by various types of rotavirus laboratory tests.(up to 2 years post-introduction of liquid formulation of Rotarix™.)
  • Occurrence of rotavirus vaccination with a specific brand of vaccine (Rotarix and RotaTeq) among children ≤5 years of age in the Belgian population.(up to 2 years post-introduction of liquid formulation of Rotarix™.)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验